DEA schedule
Is Fycompa a controlled substance?
Fycompa contains perampanel. Federal schedule from the FDA NDC directory, checked against the DEA controlled substances list.
Source: FDA NDC Directory file dated 2026-10-22. Publisher page
Yes. Fycompa (perampanel) is a Schedule III controlled substance under the federal Controlled Substances Act. Matching DEA list entry: Perampanel (Schedule III).
Run it in Rivvi
Which 2027 plans near you dropped or restricted Fycompa?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Schedule check
| Source | What it lists |
|---|---|
| FDA NDC directory | 14 prescription listings from 2 labelers, all Schedule III |
| DEA controlled substances list | Perampanel: Schedule III |
DEA list entry
| Substance | DEA code | Schedule | Narcotic | Other names | Match |
|---|---|---|---|---|---|
| Perampanel | 2261 | III | No | Fycompa; [2-(2-oxo-l-phenyl-5-pyridin-2-yl-l ,2- | Listed by name |
Fycompa NDC listings
| NDC | Product | Form | Strength | Labeler | DEA schedule |
|---|---|---|---|---|---|
| 62856-290 | Fycompa | suspension | .5 mg/mL | Eisai Inc. | CIII |
| 69616-290 | Fycompa | suspension | .5 mg/mL | Catalyst Pharmaceuticals, Inc. | CIII |
| 62856-280 | Fycompa | tablet | 10 mg/1 | Eisai Inc. | CIII |
| 69616-280 | Fycompa | tablet | 10 mg/1 | Catalyst Pharmaceuticals, Inc. | CIII |
| 62856-282 | Fycompa | tablet | 12 mg/1 | Eisai Inc. | CIII |
| 69616-282 | Fycompa | tablet | 12 mg/1 | Catalyst Pharmaceuticals, Inc. | CIII |
| 62856-272 | Fycompa | tablet | 2 mg/1 | Eisai Inc. | CIII |
| 69616-272 | Fycompa | tablet | 2 mg/1 | Catalyst Pharmaceuticals, Inc. | CIII |
| 62856-274 | Fycompa | tablet | 4 mg/1 | Eisai Inc. | CIII |
| 69616-274 | Fycompa | tablet | 4 mg/1 | Catalyst Pharmaceuticals, Inc. | CIII |
| 62856-276 | Fycompa | tablet | 6 mg/1 | Eisai Inc. | CIII |
| 69616-276 | Fycompa | tablet | 6 mg/1 | Catalyst Pharmaceuticals, Inc. | CIII |
| 62856-278 | Fycompa | tablet | 8 mg/1 | Eisai Inc. | CIII |
| 69616-278 | Fycompa | tablet | 8 mg/1 | Catalyst Pharmaceuticals, Inc. | CIII |
Questions
Is Fycompa a controlled substance?
Yes. Fycompa (perampanel) is a Schedule III controlled substance under the federal Controlled Substances Act. Matching DEA list entry: Perampanel (Schedule III).
Is Fycompa a narcotic?
No. The DEA list does not mark perampanel as a narcotic (NARC = N) and places it in Schedule III. Its FDA established pharmacologic class is Noncompetitive AMPA Glutamate Receptor Antagonist.
What schedule is Fycompa?
Fycompa is Schedule III in the FDA NDC directory, which matches the DEA controlled substances list.
Does this page cover state schedules?
No. This page reports the federal schedule only. Some states schedule drugs on their own; check your state board of pharmacy.
More on Fycompa
- What is Fycompa used for?FDA label uses
- Generic for FycompaFDA Orange Book
- What is Perampanel used for?FDA label uses
- Is Perampanel a controlled substance?Schedule III
- Noncompetitive AMPA Glutamate Receptor Antagonists listFDA drug class
- NDC 62856-272Fycompa NDC record
- NDC 62856-274Fycompa NDC record
- NDC 62856-276Fycompa NDC record
- Schedule III drugs listDEA schedule